1P-LSD
Chemical compound
1P-LSD Legal status
AU : S8 (Controlled drug)
BR : Class F2 (Prohibited psychotropics)
CA : Unscheduled.
DE : NpSG (Industrial and scientific use only)
UK : Under Psychoactive Substances Act
US : Unscheduled (may be considered illegal if sold for human consumption as an analog of LSD under the federal analogue act)
UN : Unscheduled
In general Unscheduled, unless that was sold for human consumption, could be sold for medical and research purposes.
(6aR ,9R )-N ,N -Diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg ]quinoline-9-carboxamide
CAS Number PubChem CID ChemSpider UNII CompTox Dashboard (EPA ) Formula C 23 H 29 N 3 O 2 Molar mass 379.504 g·mol−1 3D model (JSmol )
CCN(CC)C(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C(=O)CC)c4cccc(C2=C1)c34
InChI=1S/C23H29N3O2/c1-5-21(27)26-14-15-12-20-18(17-9-8-10-19(26)22(15)17)11-16(13-24(20)4)23(28)25(6-2)7-3/h8-11,14,16,20H,5-7,12-13H2,1-4H3/t16-,20-/m1/s1
Key:JSMQOVGXBIDBIE-OXQOHEQNSA-N
1P-LSD (1-propanoyl-lysergic acid diethylamide ) is a psychedelic drug of the lysergamide class that is a derivative and functional analogue of LSD and a homologue of ALD-52 . It originated in 2015 when it appeared a designer drug sold online.[1] [2] [3] [4] [5] [6] It modifies the LSD molecule by adding a propionyl group to the nitrogen molecule of LSD's indole group.[7] [8]
Pharmacology
Like ALD-52, 1P-LSD is believed to act as prodrug for LSD via hydrolysis of the propionyl group. When 1P-LSD is incubated in human serum,[9] administered intravenously to rats,[10] or administered either orally or intravenously to human subjects,[11] high levels of LSD and relatively low levels of 1P-LSD are quickly detected, demonstrating that 1P-LSD is rapidly hydrolyzed into LSD in vivo following ingestion. Indeed, following intravenous administration in humans 1P-LSD is detectable in serum for no longer than 4 hours, after which it is completely converted to LSD.[11] These findings are supported by the similar duration and behavioral effects of 1P-LSD and LSD in both animal and human experiments.[9] [11]
Effects
1P-LSD on blotter paper
The subjective effects of 1P-LSD are not well defined in the scientific literature, although they are generally thought to be comparable to that of LSD.[12] In a 2020 study, the qualitative effects of 1P-LSD and LSD were similar when measured using visual analog scales .
Legal status
As of 2015, 1P-LSD is unscheduled in the United States and Canada , but may be considered illegal if sold or used for human consumption as a structural analog of LSD under the Federal Analogue Act in the US.[9] 1P-LSD is a prohibited or controlled substance in Australia, France,[13] Finland,[14] Denmark,[15] Germany,[16] Estonia,[17] Japan,[18] Latvia,[19] Norway,[20] Romania,[21] Sweden,[22] Switzerland,[23] United Kingdom,[24] Italy,[citation needed ] Singapore,[25] the Czech Republic,[26] and Croatia.[27] 1P-LSD has been illegal in Russia since 2017 as an LSD derivative.[28]
See also
References
^ "Philtre Bulletin Issue 5" (PDF) . WEDINOS. March 2015. Retrieved 28 July 2015 .
^ Daly M (27 July 2015). "Why Young Brits Are Taking So Much LSD and Ecstasy" . Vice. Retrieved 11 August 2015 .
^ "Newer Unregulated Drugs" (PDF) . KFx. April 2015. Retrieved 13 August 2015 .
^ Speiser M (11 August 2015). "A handful of dangerous new legal drugs has public health experts worried" . Business Insider UK . Retrieved 13 August 2015 .
^ "1P-LSD" . New Synthetic Drugs Database. Archived from the original on 2016-07-03. Retrieved 2016-01-29 .
^ Palamar JJ, Acosta P, Sherman S, Ompad DC, Cleland CM (November 2016). "Self-reported use of novel psychoactive substances among attendees of electronic dance music venues" . The American Journal of Drug and Alcohol Abuse . 42 (6): 624–632. doi :10.1080/00952990.2016.1181179 . PMC 5093056 . PMID 27315522 .
^ Jose (15 October 2015). "Is 1P-LSD A Prodrug To LSD?" . Detect-Kit. Archived from the original on 2015-10-15. Retrieved 15 October 2015 .
^ Linda P, Stener A, Cipiciani A, Savelli G (January–February 1983). "Hydrolysis of amides. Kinetics and mechanism of the basic hydrolysis of N-acylpyrroles, N-acylindoles and N-acylcarbazoles". Journal of Heterocyclic Chemistry . 20 (1): 247–248. doi :10.1002/jhet.5570200154 .
^ a b c Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, et al. (September 2016). "Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)" . Drug Testing and Analysis . 8 (9): 891–902. doi :10.1002/dta.1884 . PMC 4829483 . PMID 26456305 .
^ Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, et al. (August 2020). "Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)" . Neuropharmacology . 172 : 107856. doi :10.1016/j.neuropharm.2019.107856 . PMC 9191647 . PMID 31756337 .
^ a b c Grumann C, Henkel K, Brandt SD, Stratford A, Passie T, Auwärter V (August 2020). "Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration" . Drug Testing and Analysis . 12 (8): 1144–1153. doi :10.1002/dta.2821 . PMID 32415750 .
^ Schifano F, Orsolini L, Papanti D, Corkery J (June 2016). "NPS: Medical Consequences Associated with Their Intake" . Current Topics in Behavioral Neurosciences . 32 : 351–380. doi :10.1007/7854_2016_15 . ISBN 978-3-319-52442-9 . OCLC 643052237 . PMID 27272067 .
^ "Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants" . www.legifrance.gouv.fr (in French). 20 May 2021.
^ "Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista annetun valtioneuvoston asetuksen liitteen muuttamisesta" [Government decree amending the annex to the government decree on psychoactive substances prohibited on the consumer market] (in Finnish).
^ "Lists of euphoriant substances" . The Danish Medicines Agency. September 2015.
^ "Verordnung zur Änderung der Anlage des Neue-psychoaktive-. Stoffe-Gesetzes und von Anlagen des Betäubungsmittelgesetzes" [Regulation amending the Annex to the New Psychoactive Substances Act and Appendices to the Narcotics Act] (in German).
^ "Muudatus narkootiliste ja psühhotroopsete ainete I nimekirjas" (in Estonian). Republic of Estonia Agency of Medicines. Archived from the original on 2019-04-25. Retrieved 2019-02-04 .
^ "指定薬物一覧" (PDF) (in Japanese). Ministry of Health, Labour and Welfare.
^ "Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem" (in Latvian). Latvijas Republikas tiesību akti.
^ "31 Forskrift om narkotika (narkotikaforskriften)" (in Norwegian). Helse- og omsorgsdepartementet. 14 February 2013.
^ "Legea 194/2011 privind combaterea operatiunilor cu produse susceptibile de a avea efecte psihoactive, altele decat cele prevazute de acte normative in vigoare, republicata 2014" . www.dreptonline.ro . Retrieved 2020-07-24 .
^ "Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" [Ordinance (1999: 58) on the prohibition of certain dangerous goods] (PDF) (in Swedish).
^ "Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien" (in German). Der Bundesrat.
^ "Psychoactive Substances Act 2016" . legislation.gov.uk . Retrieved 28 November 2023 .
^ "Misuse of Drugs Act - Singapore Statutes Online" . sso.agc.gov.sg .
^ "Nařízení vlády č. 463/2013 Sb. Nařízení vlády o seznamech návykových látek" (in Czech). Zákony pro lidi.
^ "Popis droga, psihotropnih tvari i biljaka iz kojih se može dobiti droga te tvari koje se mogu uporabiti za izradu droga" . narodne-novine.nn.hr . Retrieved 2023-01-02 .
^ "ИЗМЕНЕНИЯ, КОТОРЫЕ ВНОСЯТСЯ В АКТЫ ПРАВИТЕЛЬСТВА РОССИЙСКОЙ ФЕДЕРАЦИИ В СВЯЗИ С СОВЕРШЕНСТВОВАНИЕМ КОНТРОЛЯ ЗА ОБОРОТОМ НАРКОТИЧЕСКИХ СРЕДСТВ И ПСИХОТРОПНЫХ ВЕЩЕСТВ \ КонсультантПлюс" . www.consultant.ru . Retrieved 2023-02-07 .
Psychedelics (5-HT2A agonists)
Benzofurans Lyserg‐ amides Phenethyl‐ amines
2C-x
3C-x 4C-x DOx HOT-x MDxx Mescaline (subst.) TMAs
TMA
TMA-2
TMA-3
TMA-4
TMA-5
TMA-6
Others
Piperazines Tryptamines
alpha -alkyltryptaminesx -DALT x -DET x -DiPT x -DMT
4,5-DHP-DMT
2,N,N-TMT
4-AcO-DMT
4-HO-5-MeO-DMT
4,N,N-TMT
4-Propionyloxy-DMT
5,6-diBr-DMT
5-AcO-DMT
5-Bromo-DMT
5-MeO-2,N ,N -TMT
5-MeO-4,N ,N -TMT
5-MeO-α,N,N-TMT
5-MeO-DMT
5-N ,N -TMT
7,N,N-TMT
α,N,N-TMT
(Bufotenin) 5-HO-DMT
DMT
Norbaeocystin
(Psilocin) 4-HO-DMT
(Psilocybin) 4-PO-DMT
x -DPT Ibogaine-related x -MET x -MiPT Others
Others
Dissociatives (NMDAR antagonists )
Deliriants (mAChR antagonists ) Others